A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Aciclovir
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Fallopian tube cancer+1

Not yet recruiting

Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

Registered drugNo placebo

Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Glatiramer Acetate
Sponsor:Torl Biotherapeutics LLC

Contact Research Centre

Medulloblastoma

Not yet recruiting

Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

Registered drugNo placebo

Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Carboplatin
Sponsor:GPOH gGmbH

Contact Research Centre

Loss of consciousness

Not yet recruiting

Study on Zolpidem's Effects in Patients with Vision Impairments, Disorders of Consciousness, and Neurotypical Volunteers

Registered drug

Study on Zolpidem's Effects in Patients with Vision Impairments, Disorders of Consciousness, and Neurotypical Volunteers

Registered drug

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Mannitol
Sponsor:Universite De Liege

Contact Research Centre

Breast cancer+2

Not yet recruiting

A study of Zr89-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

Registered drugNo placebo

A study of Zr89-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Trastuzumab
Sponsor:Institut Jules Bordet

Contact Research Centre

Colitis ulcerative

Not yet recruiting

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Adalimumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Narcolepsy

Not yet recruiting

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Investigational

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3',5'-Trifluoro[1,1'-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Brain injury+1

Not yet recruiting

Study on Ketamine for Treating Patients with Severe Brain Injury and Disorders of Consciousness

Registered drug

Study on Ketamine for Treating Patients with Severe Brain Injury and Disorders of Consciousness

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Ketamine
Sponsor:Centre hospitalier universitaire de Liege

Contact Research Centre

Plasma cell myeloma

Not yet recruiting

Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

Registered drugNo placebo

Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Carfilzomib
Sponsor:Intergroupe Francophone Du Myelome

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Liege

What the registry says about research in the country

01 Infectious Disease Research

Groundbreaking vaccine trials focusing on chickenpox, cytomegalovirus, and respiratory syncytial virus. These studies aim to evaluate immune responses and develop effective prevention strategies for vulnerable populations.

Varicella vaccine safety in children
CMV prevention in young adults
RSV protection in transplant recipients

02 Oncology Studies

Advanced research into various cancer treatments, particularly focusing on lung cancer and gastric cancer. Trials evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.

Non-small cell lung cancer therapies
Hematological cancer treatments
Advanced breast cancer interventions

03 Autoimmune Conditions

Innovative trials investigating treatments for inflammatory bowel disease, psoriasis, and chronic inflammatory conditions. Research focuses on developing targeted therapies and understanding disease mechanisms.

IBD pain management studies
Plaque psoriasis treatments
Inflammatory polyneuropathy therapies

Back to Belgium All countries